| CTVA | Corteva — lobbying disclosures Corteva filed quarterly lobbying disclosures with Congress. →Agricultural biotechnology and seed regulations remain under active discussion as Corteva files quarterly lobbying disclosure, continuing the company's engagement on farm policy and chemical approval processes. |
|
| FDX | FedEx — lobbying disclosures FedEx filed quarterly lobbying disclosures with Congress. →Logistics infrastructure and labor policy intersect with commerce as FedEx updates its lobbying activity, maintaining its presence in discussions around transportation funding and gig economy regulation. |
|
| UAL | United Airlines — lobbying disclosures United Airlines filed quarterly lobbying disclosures with Congress. →Aviation policy and infrastructure spending remain live issues as United Airlines discloses quarterly lobbying expenditures, tracking debates over air traffic modernization and slot allocations. |
|
| AAPL | Apple — lobbying disclosures Apple filed quarterly lobbying disclosures with Congress. →Tech regulation and antitrust scrutiny continue as Apple files lobbying disclosure, reflecting ongoing engagement on app store rules, privacy legislation, and foreign semiconductor sourcing. |
|
| PFE | Pfizer — lobbying disclosures Pfizer filed quarterly lobbying disclosures with Congress. →Drug pricing reform and FDA approval pathways stay in motion as Pfizer updates lobbying activity, with pharmaceutical regulation remaining a perennial focus for appropriations and health committees. |
|
| SO | Southern — lobbying disclosures Southern Company filed quarterly lobbying disclosures with Congress. →Utility regulation and clean energy mandates evolve as Southern Company discloses lobbying expenditures, engaging on transmission infrastructure and the implementation of climate provisions. |
|
| PSKY | Paramount Skydance — lobbying disclosures Paramount Skydance filed quarterly lobbying disclosures with Congress. →Media consolidation rules and content regulation advance as Paramount Skydance files lobbying disclosure, navigating merger review standards and streaming platform oversight. |
|
| VZ | Verizon — lobbying disclosures Verizon filed quarterly lobbying disclosures with Congress. →Telecommunications infrastructure and spectrum allocation remain contested as Verizon updates lobbying activity, with 5G deployment and Universal Service Fund reform still under committee review. |
|
| GS | Goldman Sachs — lobbying disclosures Goldman Sachs filed quarterly lobbying disclosures with Congress. →Financial regulation and capital requirements shift as Goldman Sachs discloses quarterly lobbying, tracking Basel III implementation and proprietary trading restrictions. |
|
| CSCO | Cisco — lobbying disclosures Cisco filed quarterly lobbying disclosures with Congress. →Network equipment security and supply chain restrictions tighten as Cisco files lobbying disclosure, engaging on federal procurement standards and Chinese component bans. |
|
| OXY | Occidental Petroleum — lobbying disclosures Occidental Petroleum filed quarterly lobbying disclosures with Congress. →Energy permitting and drilling lease terms remain fluid as Occidental Petroleum updates lobbying expenditures, with Permian Basin operations subject to evolving federal land management rules. |
|
| XOM | ExxonMobil — lobbying disclosures ExxonMobil filed quarterly lobbying disclosures with Congress. →Climate disclosure requirements and refining regulations advance as ExxonMobil files lobbying disclosure, tracking SEC emissions reporting mandates and renewable fuel standard debates. |
|
| DUK | Duke Energy — lobbying disclosures Duke Energy filed quarterly lobbying disclosures with Congress. →Grid reliability and rate structures evolve as Duke Energy discloses quarterly lobbying, engaging on transmission cost recovery and nuclear plant licensing extensions. |
|
| CVX | Chevron — lobbying disclosures Chevron filed quarterly lobbying disclosures with Congress. →Carbon border adjustments and LNG export approvals shift as Chevron updates lobbying activity, with natural gas infrastructure policy under active committee consideration. |
|
| MO | Altria — lobbying disclosures Altria filed quarterly lobbying disclosures with Congress. →Tobacco regulation and flavor bans remain in flux as Altria files lobbying disclosure, tracking FDA menthol restrictions and synthetic nicotine product classification. |
|
| QCOM | Qualcomm — lobbying disclosures Qualcomm filed quarterly lobbying disclosures with Congress. →Semiconductor subsidies and wireless standards evolve as Qualcomm discloses lobbying expenditures, engaging on CHIPS Act implementation and 6G research funding. |
|
| C | Citigroup — lobbying disclosures Citigroup filed quarterly lobbying disclosures with Congress. →Bank capital rules and stress testing thresholds adjust as Citigroup updates lobbying activity, with Fed supervision intensity and resolution planning requirements under review. |
|
| FOX | Fox Corporation(Class B) — lobbying disclosures Fox Corporation filed quarterly lobbying disclosures with Congress. →Media ownership limits and broadcast licensing shift as Fox Corporation files lobbying disclosure, navigating retransmission consent rules and local station cross-ownership restrictions. |
|
| AMZN | Amazon — lobbying disclosures Amazon filed quarterly lobbying disclosures with Congress. →Antitrust enforcement and labor organizing intensify as Amazon discloses quarterly lobbying, with FTC challenges to acquisitions and NLRB warehouse union elections proceeding simultaneously. |
|
| TMUS | T-Mobile US — lobbying disclosures T-Mobile US filed quarterly lobbying disclosures with Congress. →Wireless merger conditions and rural broadband mandates advance as T-Mobile updates lobbying expenditures, tracking Sprint integration commitments and 5G coverage requirements. |
|
| PSX | Phillips 66 — lobbying disclosures Phillips 66 filed quarterly lobbying disclosures with Congress. →Renewable fuel blending and refinery margin regulations shift as Phillips 66 files lobbying disclosure, engaging on biofuel mandates and gasoline export policy. |
|
| JNJ | Johnson & Johnson — lobbying disclosures Johnson & Johnson filed quarterly lobbying disclosures with Congress. →Medical device taxation and patent litigation reform evolve as Johnson & Johnson discloses quarterly lobbying, with talc liability legislation and Inflation Reduction Act drug pricing provisions under ongoing debate. |
|